⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Roslyn EinbinderMD

Neurology · New Haven, CT 06510

NPI: 1134210289

Share:𝕏fin

36

🟠 Elevated

Risk Flags

Extreme opioid rate vs specialty peersElevated cost per beneficiaryHigh long-acting opioid rate vs peers

Risk indicators are statistical patterns, not allegations. Learn more

403

Total Claims

$233K

Drug Cost

42

Beneficiaries

$5,536

Cost/Patient

Risk Score Breakdown 36/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid rate vs specialty peers+25
Long-acting opioid rate+8
Cost per patient outlier+3

Score components are additive. Read full methodology

Peer Comparison vs. 13,194 Neurology providers

+2158%

Opioid rate vs peers

29.5% vs 1.3% avg

+37%

Cost per patient vs peers

$5,536 vs $4,034 avg

⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.

Opioid Prescribing

29.5%

Opioid Rate

119

Opioid Claims

$7,450

Opioid Cost

50.4%

Long-Acting Rate

This provider's opioid prescribing rate of 29.5% is above the 20% threshold that CMS considers elevated.

Brand vs Generic

100% generic

Brand: 0 claims · $0

Generic: 334 claims · $12K

Patient Profile

73

Avg Age

Female

1.14

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About